Introduction
============

Acute respiratory distress syndrome (ARDS) is edema that appears in diffuse pulmonary interstitial and alveolus and is caused by a variety of serious intrapulmonary and extrapulmonary diseases. The diseases facilitate the increase of lung water content, the decrease of lung volume, the continuous reduction of lung compliance and the collapse of alveolus. ARDS severely affects the function of ventilation and blood flow exchange ([@b1-etm-0-0-7218],[@b2-etm-0-0-7218]). The fatality rate of ARDS is extremely high, and progressive respiratory distress and refractory hypoxemia are clinical syndromes characterized by ARDS ([@b3-etm-0-0-7218],[@b4-etm-0-0-7218]). ARDS is a complicated syndrome whose nosogenesis is multifactorial due to the involvement of different pathogenies ([@b5-etm-0-0-7218],[@b6-etm-0-0-7218]). Respiratory mechanics, early central drive and hemodynamics are commonly used as observation indicators of ARDS ([@b7-etm-0-0-7218],[@b8-etm-0-0-7218]).

Mechanical ventilation therapy and non-mechanical ventilation therapy are the two main methods for the treatment of ARDS ([@b9-etm-0-0-7218]). Recruitment maneuver (RM) is mechanical ventilation therapy, which reopens the alveoli without ventilation or hypoventilation and improves the compliance of oxygenation and respiratory system. Mechanical ventilation therapy is an important treatment for ARDS ([@b10-etm-0-0-7218]). The common RM techniques include sustained inflation (SI) ([@b11-etm-0-0-7218]), pressure-controlled ventilation (PCV) ([@b12-etm-0-0-7218]), and IP ([@b13-etm-0-0-7218]). The most basic mechanical modes for patients with ARDS are SI and PCV ([@b14-etm-0-0-7218]). As a method which promotes RM of collapsed alveoli, SI can significantly improve lung compliance, oxygenation, and offset the disadvantages that collapsed alveoli hardly can achieve RM when the lung protective ventilation is strategized ([@b15-etm-0-0-7218]). PCV refers to a process in which the airway pressure and inspiratory time of the respirator are set up in advance. When the airflow enters the lungs quickly and the pressure level in the lungs is equal to the preset pressure level, the speed of the ventilative airflow will slow down and the preset pressure level of the respirator is maintained until the termination of inhaling and then exhaling ([@b12-etm-0-0-7218]). However, there are few studies relating to advantages and disadvantages of the effects of SI and PCV on respiratory mechanics, early central drive and hemodynamics in the treatment of patients with ARDS. This study compared the efficacy and safety of the two RM methods by observing the effects of SI and PCV on respiratory mechanics, early central drive and hemodynamics in patients with ARDS.

Patients and methods
====================

### Patient information

Twenty-six patients with ARDS who were admitted to the Yiwu Central Hospital (Yiwu, China) from March 2015 to March 2016 were selected. According to the ventilation method adopted by the patients with ARDS, 13 patients with ARDS who were treated with SI were included in the SI group, including 8 males and 5 females. The age range was from 30 to 66 years, and the average age was 48.03±10.01 years; 13 patients with ARDS who were treated with PCV were included in the PCV group, including 7 males and 6 females. The age range was from 29 to 65 years, and the average age was 48.04±10.03 years. Inclusion and exclusion criteria were: All selected people conformed to the diagnostic criteria of WHO for ARDS ([@b3-etm-0-0-7218]). Patients who were \<18 years old and had serious intracranial hypertension; with pneumothorax, bronchopleural fistula, chronic obstructive pulmonary disease, and hemodynamic instability (systolic pressure \>180 or \<90 mmHg); who received pulmonary lobectomy within 2 weeks; who had arrhythmia during RM (heart rate \>140 beats/min); whose heart rates increased by 20 times/min after RM; whose arterial systolic pressure was abnormal (systolic pressure \<90 mmHg); whose arterial systolic pressure decreased by 30 mmHg after RM; whose percutaneous arterial oxyhemoglobin saturation was abnormal (percutaneous arterial oxyhemoglobin saturation \<90%) and whose percutaneous arterial oxyhemoglobin saturation decreased by \>5% after RM, were excluded.

This study was approved by the Ethics Committee of the Yiwu Central Hospital. Patients who participated in this research had complete clinical data. The signed informed consents were obtained from the patients or the guardians. When comparing the general data of the patients in the two groups, there was no statistically significant differences (P\>0.05) ([Table I](#tI-etm-0-0-7218){ref-type="table"}).

### Main instruments

Puritan Bennett 840 respirator (20160077; Shanghai Jumu Medical Devices Co., Ltd., Shanghai, China).

### Methods

All patients with ARDS took the supine position during the mechanical ventilation. The secretions in airway of patients were completely cleared away before the artificial airway was established, and after patients were sedated and given analgesic, they were treated with ventilation therapy by connecting Puritan Bennett 840 respirator (20160077; Shanghai Jumu Medical Devices Co., Ltd.). A low tidal volume of 6--8 ml/k were used to control ventilation, and breathing rate was regulated at the frequency of 15 times/min. The vital signs and blood gas analysis of all patients were closely monitored during the RM. The RM was used once in each group. Controlling lung expansion, one of the RM strategies, was used in the SI group: The respirator mode was adjusted to CPAP mode. The positive end-expiratory pressure ventilation was maintained at 5 cm H~2~O, the inspiratory pressure was from 30 to 45 cm H~2~O, and the duration was 20 sec. Pressure controlled ventilation was used in the PCV group: The respirator mode was adjusted to BIPAP mode. The pressure was adjusted to a high pressure of 40 cm H~2~O and a low pressure of 20 cm H~2~O, and this condition was maintained for 2 min, then the ventilation condition and mode were recovered to what it used to be.

Observation indicators
----------------------

### i) Respiratory mechanics

The indicators of respiratory mechanics before and after RM at 1, 10, 20 and 30 min were monitored: Peak inflation pressure (PIP) cmH~2~O, plateau pressure (Pplate) cmH~2~O, and compliance of the respiratory system (Crs) ml/cmH~2~O/kg.

### ii) Early central drive

The indicators of central-mechanical-ventilation coupling before and after RM were monitored, including VE/RMS (l/µV), VT/RMS (ml/µV), ΔPdi/RMS (cmH~2~O/µV); VT/RMS and VE/RMS reflected central-ventilation coupling and ΔPdi/RMS reflected central-mechanical coupling.

### iii) Hemodynamics

Heart rate (HR), mean arterial pressure (MAP), and central venous pressure (CVP) were monitored and recorded before and after RM at 1, 10, 20 and 30 min.

Statistical analysis. SPSS 17.0 software system (SPSS, Inc., Chicago, IL, USA) was used to carry out the statistical analysis. The enumeration data were expressed in the form of \[n (%)\]. The measurement data were expressed as the mean ± SD. Independent-samples t-test was used in the comparison of the data between two groups, and χ^2^ test was used in the enumeration data. One-way ANOVA test with Least Significant Difference test was used in the comparison of the data between groups. At P\<0.05 the difference was statistically significant.

Results
=======

### Comparison of each indicator of respiratory mechanics between two groups

### i) Comparison of PIP between two groups

The differences were not statistically significant when comparing PIP in patients in the SI group and the PCV group before RM with that after RM at 1, 10, 20 and 30 min (P\>0.05). The comparison within the group showed that when the peak of PIP in patients in the SI group and the PCV group appeared at 1 min after RM, PIP was significantly higher than that before RM (P\<0.05). PIP of both groups gradually decreased after RM, and the comparison of PIP at different time-points showed that the differences were statistically significant (P\<0.05) ([Table II](#tII-etm-0-0-7218){ref-type="table"}).

### ii) Comparison of Pplate between two groups

The differences were not statistically significant when comparing Pplate in patients in the SI group and the PCV group before RM with that after RM at 1, 10, 20 and 30 min (P\>0.05). The comparison within the group showed that when the peak of Pplate in patients in the SI group and the PCV group appeared at 1 min after RM, Pplate was significantly higher than that before RM (P\<0.05). Pplate of both groups gradually decreased after RM, and the comparison of Pplate at different time-points showed that the differences were statistically significant (P\<0.05) ([Table III](#tIII-etm-0-0-7218){ref-type="table"}).

### iii) Comparison of Crs between two groups

The differences were not statistically significant when comparing Crs in patients in the SI group and the PCV group before RM with that after RM at 1, 10, 20 and 30 min (P\>0.05). The comparison within the group showed that when the valley value of Crs in patients in the SI group and the PCV group appeared at 1 min after RM, Crs was significantly lower than that before RM (P\<0.05). Crs in the two groups showed an upward trend from 1 to 10 min after RM, but Crs in the two groups showed a downward trend from 10 to 30 min after RM, and the comparison of Crs at different time-points showed that the differences were statistically significant (P\<0.05) ([Table IV](#tIV-etm-0-0-7218){ref-type="table"}).

Comparison of the changes of each indicator of early central drive in the two groups before and after RM. Before RM, VT/RMS was 23.01±9.02 ml/µV, VE/RMS was 0.20±0.04 l/µV, ΔPdi/RMS was 0.37±0.18 cm H~2~O/µV. VT/RMS in the SI group and the PCV group after RM was respectively 40.03±11.36 and 39.65±11.06 ml/µV, which were both significantly higher than VT/RMS before RM, and the differences were statistically significant (P\<0.05); VE/RMS in the SI group and the PCV group after RM, respectively were 0.64±0.12 and 0.65±0.14 l/µV, which were significantly higher than VE/RMS before RM, and the differences were statistically significant (P\<0.05); ΔPdi/RMS in the SI group and the PCV group after RM respectively were 0.57±0.11 cm H~2~O/µV and 0.55±0.12 cm H~2~O/µV, which were both significantly higher than ΔPdi/RMS before RM, and the differences were statistically significant (P\<0.05); the differences were not statistically significant when comparing VT/RMS, VE/RMS, ΔPdi/RMS in the SI group with those in the PCV group after RM (P\>0.05) ([Table V](#tV-etm-0-0-7218){ref-type="table"} and [Fig. 1](#f1-etm-0-0-7218){ref-type="fig"}).

Comparison of each indicator of hemodynamics in the two groups
--------------------------------------------------------------

### i) Comparison of HR between two groups

The differences were not statistically significant when comparing HR in patients in the SI group and the PCV group before RM with that after RM at 1, 10, 20 and 30 min (P\>0.05). The comparison within the group showed that when the peak of HR in patients in the SI and the PCV group appeared at 1 min after RM, HR was significantly higher than that before RM (P\<0.05). HR of both groups gradually decreased after RM, and the comparison of HR at different time-points showed that the differences were statistically significant (P\<0.05) ([Table VI](#tVI-etm-0-0-7218){ref-type="table"}).

### ii) Comparison of MAP between two groups

The differences were not statistically significant when comparing MAP in patients in the SI group and the PCV group before RM with that after RM at 1, 10, 20 and 30 min (P\>0.05). The comparison within the group showed that when the valley value of MAP in patients in the SI group and the PCV group appeared at 1 min after RM, MAP was significantly lower than that before RM (P\<0.05). MAP of both groups gradually increased after RM, and the comparison of MAP at different time-points showed that the differences were statistically significant (P\<0.05) ([Table VII](#tVII-etm-0-0-7218){ref-type="table"}).

### iii) Comparison of CVP between two groups

When the two groups were compared, it was found that there were no significant differences between the two groups before RM and at 1 and 30 min after RM. CVP in patients in the SI group at 10 and 20 min after RM was significantly higher than that in the PCV group, and the difference was statistically significant (P\<0.05). The comparison within the group showed that when the peak of CVP in patients in the SI group and the PCV group appeared at 1 min after RM, CVP was significantly higher than that before RM (P\<0.05). CVP of both groups gradually decreased after RM, and the comparison of CVP at different time-points showed that the difference was statistically significant (P\<0.05) ([Table VIII](#tVIII-etm-0-0-7218){ref-type="table"}).

Discussion
==========

The mortality of patients with ARDS is up to 39--69%. The obvious decrease of pulmonary volume and the uneven lesions are the important features of ARDS ([@b16-etm-0-0-7218]). It has been reported that the incidence of patients with ARDS is closely related to the indicators of respiratory function in their own biological mechanism, including PIP, Pplate, Crs, the condition of central-mechanical-ventilation coupling before and after RM, hemodynamics, HR, MAP, and CVP ([@b8-etm-0-0-7218]). The treatment of ARDS is mainly based on the active treatment of protopathy, and patients with ARDS are treated with mechanical ventilation to prevent further lung damage and reduce acute lung damage or the case fatality rate of ARDS ([@b16-etm-0-0-7218],[@b17-etm-0-0-7218]). In the process of mechanical ventilation, the occurrence of high airway pressure is frequent, which will result in barotrauma. The traditional volumetric ventilation mode easily results in barotrauma due to the constant volume and high peak pressure, and different ventilation modes may have different effects on patients with ARDS ([@b18-etm-0-0-7218],[@b19-etm-0-0-7218]). RM is an important means for the treatment of ARDS. There are many types of RM used in clinical practice, among which SI and PCV are commonly used for the treatment of ARDS ([@b20-etm-0-0-7218]). At present, there are few studies on the advantages and disadvantages of the effects of SI and PCV on respiratory mechanics, early central drive and hemodynamics in the treatment of patients with ARDS. This study compared the efficacy and safety of the two RM methods by observing the effects of SI and PCV on respiratory mechanics, early central drive and hemodynamics in patients with ARDS.

In this study, according to the ventilation method adopted by patients with ARDS, 13 patients who received SI treatment were included in the SI group. At the same time, 13 patients who received PCV treatment were included in the PCV group. The changes of respiratory mechanics, early central drive and hemodynamics in the two groups before RM were compared with those after RM. The comparison of each indicator of respiratory mechanics in the two groups showed that the differences were not statistically significant when comparing PIP, Pplate and Crs in patients in the SI group and the PCV group before RM with those after RM at 1, 10, 20 and 30 min (P\>0.05). However, the comparison of each indicator of hemodynamics in the two groups showed that the differences were not statistically significant when comparing HR and MAP in patients in the SI group and the PCV group before RM with those after RM at 1, 10, 20 and 30 min (P\>0.05). When comparing the two groups with each other, the CVP in patients in the SI group after RM at 10 and 20 min was significantly higher than that in the PCV group, and the differences were statistically significant (P\<0.05). Based on the above results, we speculated that there was little difference in the effect between SI and PCV on respiratory mechanics in patients with ARDS, but the CVP in patients in the SI group after RM at 10 and 20 min was significantly higher than that in the PCV group, which suggested that SI had a greater effect than PCV on hemodynamics in patients with ARDS. At present, there are few studies related to the effects of the mechanical ventilation methods SI and PCV, on respiratory mechanics and hemodynamics in patients with ARDS. Some studies have shown that there is little difference in the effect between SI and PCV on respiratory mechanics and hemodynamics in patients with ARDS; the two mechanical ventilation methods, SI and PCV, are equally available for patients with ARDS. There is no conclusion that one ventilation method could replace another kind of ventilation method ([@b21-etm-0-0-7218],[@b22-etm-0-0-7218]). The changes of each indicator of early central drive in patients in the two groups before and after RM showed that VT/RMS, VE/RMS and ΔPdi/RMS in the SI group and the PCV group after RM were both significantly higher than those before RM, and the differences were statistically significant (P\<0.05). However, when respectively comparing VT/RMS, VE/RMS and ΔPdi/RMS in the SI group after RM with those in the PCV group after RM, and the differences were not statistically significant (P\>0.05). Therefore, we believed that the two mechanical ventilation methods, SI and PCV, had similar effects on early central drive in patients with ARDS, and could enhance the effect of central-mechanical-ventilation coupling after RM. There are few studies on the effects of SI and PCV on early central drive in patients with ARDS, but we still consulted a small number of studies which were related to the effect of early central drive in patients with ARDS to support the rationality of the results of this study ([@b23-etm-0-0-7218]).

In this study, the number of enrolled patients was small, which may result in some contingency on the results. In conclusion, there is little difference between the effect of SI and PCV on respiratory mechanics and early central drive and hemodynamics in patients with ARDS, and both of the mechanical ventilation methods can enhance the effect of central-mechanical-ventilation coupling after RM. Therefore, the mechanical ventilation methods SI and PCV, are equally available for patients with ARDS.
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###### 

Comparison of the general data of the patients in the two groups.

  General data        SI group (n=13)   PCV group (n=13)   t/χ^2^ test   P-value
  ------------------- ----------------- ------------------ ------------- ---------
  Sex                                                                    
    Male              8 (61.54)         7 (53.85)          0.158         0.691
    Female            5 (38.46)         6 (46.15)                        
  Age (years)                                                            
    ≤48               5 (38.46)         6 (46.15)          0.158         0.691
    \>48              8 (61.54)         7 (53.85)                        
  BMI (kg/m^2^)                                                          
    ≤18.25            9 (69.23)         8 (61.54)          0.170         0.680
    \>18.25           4 (30.77)         5 (38.46)                        
  Blood routine                                                          
    Hb (gm/dl)        8.23±1.86         11.63±2.63         3.806         \<0.001
    RBC (×10^12^/l)   4.28±0.37         4.19±0.35          0.637         0.530
    PLT (×10^9^/l)    148.63±22.78      151.63±25.61       0.316         0.755
  Liver function                                                         
    ALT (U/l)         22.41±10.43       20.41±8.45         0.537         0.596
    AST (U/l)         19.35±8.63        17.48±7.24         0.599         0.555
  Renal function                                                         
    TP (g/l)          130.50±10.44      75.98±10.23        13.450        \<0.001
    UREA (mmol/l)     8.09±1.03         4.12±1.67          7.295         \<0.001
    CRE (µmol/l)      200.56±20.12      98.49±18.08        13.610        \<0.001
    UA (µmol/l)       629.45±40.76      204.84±56.19       22.050        \<0.001

###### 

Comparison of PIP (cmH~2~O) in the patients in the two groups.

  Index                SI group (n=13)                                            PCV group (n=13)                                           t-test   P-value
  -------------------- ---------------------------------------------------------- ---------------------------------------------------------- -------- ---------
  Before RM            27.01±8.34                                                 28.46±8.05                                                 0.451    0.656
  After RM at 1 min    48.35±6.75^[a](#tfn1-etm-0-0-7218){ref-type="table-fn"}^   46.02±6.48^[a](#tfn1-etm-0-0-7218){ref-type="table-fn"}^   0.898    0.378
  After RM at 10 min   31.51±6.01^[b](#tfn2-etm-0-0-7218){ref-type="table-fn"}^   34.39±5.04^[b](#tfn2-etm-0-0-7218){ref-type="table-fn"}^   1.324    0.198
  After RM at 20 min   26.77±8.01                                                 27.39±5.97                                                 0.825    0.224
  After RM at 30 min   23.58±7.93                                                 25.59±6.49                                                 0.707    0.486
  F-test               22.720                                                     21.400                                                              
  P-value              \<0.001                                                    \<0.001                                                             

The difference was statistically significant when compared with that at different time-points in the group (P\<0.05)

the difference was statistically significant when compared with that after RM at 30 min in the group (P\<0.05)

###### 

Comparison of Pplate (cmH~2~O) in the patients in the two groups.

  Index                SI group (n=13)                                            PCV group (n=13)                                           t-test   P-value
  -------------------- ---------------------------------------------------------- ---------------------------------------------------------- -------- ---------
  Before RM            23.74±5.07                                                 23.01±5.27                                                 0.722    0.360
  After RM at 1 min    39.43±6.68^[a](#tfn3-etm-0-0-7218){ref-type="table-fn"}^   39.47±4.52^[a](#tfn3-etm-0-0-7218){ref-type="table-fn"}^   0.018    0.986
  After RM at 10 min   24.19±4.06                                                 25.56±5.02                                                 0.765    0.452
  After RM at 20 min   23.06±3.96                                                 23.03±3.74                                                 0.020    0.984
  After RM at 30 min   20.83±4.69                                                 21.79±4.99                                                 0.505    0.618
  F-test               29.210                                                     31.180                                                              
  P-value              \<0.001                                                    \<0.001                                                             

The difference was statistically significant when compared with that at different time-points in the group (P\<0.05)

###### 

Comparison of Crs (ml/cmH~2~O/kg) in the patients in the two groups.

  Index                SI group (n=13)                                            PCV group (n=13)                                           t-test   P-value
  -------------------- ---------------------------------------------------------- ---------------------------------------------------------- -------- ---------
  Before RM            39.34±11.82                                                38.49±12.03                                                0.182    0.858
  After RM at 1 min    28.03±8.33^[a](#tfn4-etm-0-0-7218){ref-type="table-fn"}^   27.57±7.92^[a](#tfn4-etm-0-0-7218){ref-type="table-fn"}^   0.144    0.887
  After RM at 10 min   38.90±10.36                                                37.64±11.57                                                0.293    0.772
  After RM at 20 min   36.94±6.69                                                 35.59±6.81                                                 0.510    0.615
  After RM at 30 min   34.90±7.04                                                 34.78±6.88                                                 0.044    0.965
  F-test               3.342                                                      2.786                                                               
  P-value              0.016                                                      0.034                                                               

The difference was statistically significant when compared with that before RM and after RM at 10 min in the group (P\<0.05)

###### 

Comparison of the changes of each indicator of early central drive in the two groups before and after RM.

                                       After RM                                                                                                                         
  ----------------------- ------------ ----------------------------------------------------------- ----------------------------------------------------------- -------- ---------
  VT/RMS (ml/µV)          23.01±9.02   40.03±11.36^[a](#tfn5-etm-0-0-7218){ref-type="table-fn"}^   39.65±11.06^[a](#tfn5-etm-0-0-7218){ref-type="table-fn"}^   11.070   \<0.001
  VE/RMS (l/µV)           0.20±0.04    0.64±0.12^[a](#tfn5-etm-0-0-7218){ref-type="table-fn"}^     0.65±0.14^[a](#tfn5-etm-0-0-7218){ref-type="table-fn"}^     72.34    \<0.001
  ΔPdi/RMS (cmH~2~O/µV)   0.37±0.18    0.57±0.11^[a](#tfn5-etm-0-0-7218){ref-type="table-fn"}^     0.55±0.12^[a](#tfn5-etm-0-0-7218){ref-type="table-fn"}^     8.034    0.001

The group that after RM was significantly higher than that before RM, with a statistically significant difference (P\<0.05)

###### 

Comparison of HR (beat/min) in the patients in the two groups.

  Index                SI group (n=13)                                              PCV group (n=13)                                             t-test   P-value
  -------------------- ------------------------------------------------------------ ------------------------------------------------------------ -------- ---------
  Before RM            107.20±19.09                                                 108.27±22.46                                                 0.131    0.131
  After RM at 1 min    127.34±24.95^[a](#tfn6-etm-0-0-7218){ref-type="table-fn"}^   126.66±25.01^[b](#tfn7-etm-0-0-7218){ref-type="table-fn"}^   0.069    0.945
  After RM at 10 min   123.63±21.03                                                 110.41±21.68                                                 1.578    0.128
  After RM at 20 min   117.99±19.45                                                 108.05±20.85                                                 1.257    0.221
  After RM at 30 min   110.38±20.11                                                 109.42±20.43                                                 0.121    0.905
  F-test               2.140                                                        1.670                                                                 
  P-value              0.087                                                        0.169                                                                 

The difference was statistically significant when comparing the condition of the group with that in each group at each time-point, apart from the group at 10 min after RM (P\<0.05)

the difference was statistically significant when comparing the condition of the group with that in each group at each time-point (P\<0.05)

###### 

Comparison of MAP (mmHg) in the patients in the two groups.

  Index                SI group (n=13)                                             PCV group (n=13)                                            t-test   P-value
  -------------------- ----------------------------------------------------------- ----------------------------------------------------------- -------- ---------
  Before RM            83.21±18.26                                                 81.57±15.02                                                 0.250    0.805
  After RM at 1 min    70.86±11.40^[a](#tfn8-etm-0-0-7218){ref-type="table-fn"}^   71.34±12.56^[b](#tfn9-etm-0-0-7218){ref-type="table-fn"}^   0.102    0.920
  After RM at 10 min   71.94±12.73                                                 80.59±18.01                                                 1.414    0.170
  After RM at 20 min   77.80±14.99                                                 82.04±18.69                                                 0.638    0.530
  After RM at 30 min   82.92±18.76                                                 83.12±17.59                                                 0.028    0.980
  F-test               1.851                                                       1.086                                                                
  P-value              0.131                                                       0.372                                                                

The difference was statistically significant when comparing the condition of the group with that in each group at each time-point, apart from the group at 10 min after RM (P\<0.05)

the difference was statistically significant when comparing the condition of the group with that in each group at each time-point (P\<0.05)

###### 

Comparison of CVP (cmH~2~O) in the patients in the two groups.

  Index                SI group (n=13)                                             PCV group (n=13)   t-test   P-value
  -------------------- ----------------------------------------------------------- ------------------ -------- ---------
  Before RM            10.24±1.43                                                  10.68±1.11         0.876    0.390
  After RM at 1 min    15.46±1.92                                                  14.89±1.69         0.804    0.430
  After RM at 10 min   14.12±1.59^[a](#tfn10-etm-0-0-7218){ref-type="table-fn"}^   11.61±2.01         3.531    0.002
  After RM at 20 min   13.68±2.01^[a](#tfn10-etm-0-0-7218){ref-type="table-fn"}^   10.01±1.02         5.871    \<0.001
  After RM at 30 min   10.39±1.03                                                  9.59±1.30          1.739    0.095
  F-test               26.70                                                       26.85                       
  P-value              \<0.001                                                     \<0.001                     

There were statistically significant differences between this group and the PCV group at the same time-point (P\<0.05)

[^1]: Contributed equally
